Hemoglobin levels do not predict biochemical outcome for localized prostate cancer treated with neoadjuvant androgen-suppression therapy and external-beam radiotherapy

Article ID	Journal	Published Year	Pages	File Type
8245598	International Journal of Radiation OncologyBiologyPhysics	2006	9 Pages	PDF

Abstract

Conclusions: Anemia is a common side effect of NAST and is usually mild. Hb levels, however, do not predict biochemical control or survival.

Keywords

Prostate cancer Hemoglobin prostate-specific antigen external-beam radiotherapy

Related Topics

Physical Sciences and Engineering Physics and Astronomy Radiation

Preview

Hemoglobin levels do not predict biochemical outcome for localized prostate cancer treated with neoadjuvant androgen-suppression therapy and external-beam radiotherapy

Authors

Howard Huaihan M.D., F.R.C.P.C., Charles M.D., F.R.C.P.C., Tom M.D., F.R.C.P.C., Chuck M.Sc., Alex M.D., F.R.C.P.C., Eric M.D., F.R.C.P.C., Graeme M.D., F.R.C.P.C., Charmaine M.D., F.R.C.P.C., Winkle M.B.B.S., F.R.C.P.C., Jan M.B., F.R.C.P.C.,